Clinical use of natriuretic peptide

October 4, 2013

Presented by Dr James Januzzi, Mass General, USA

Playback

Slides

Heart failure is the fastest rising diagnostic condition in modern cardiology today. In the US alone, approximately one million new patients are diagnosed with heart failure each year. Many of these patients do not show any symptoms, especially in the early stages of heart failure. Because symptoms can be ambiguous, an imprecise heart failure diagnosis can lead to a poorer prognosis and longer length of stay.

Since it is difficult to recognize, adequately gauge and manage the severity of heart failure, a more objective means of diagnosis has been sought. Accurate diagnosis of heart failure is trending more and more toward clinical decisions based on laboratory results that include rapid, high-quality natriuretic peptide testing as a fundamental component of diagnosis.

This webinar will offer background on the challenges that heart failure diagnosis presents to physicians and hospitals, and discuss the effect of natriuretic peptide testing on patient outcomes. It will review lab testing strategies and analyze clinical interpretation of and response to natriuretic peptide values. The session will also discuss short- and long-term applications of natriuretic peptide testing to simplify the diagnosis of heart failure, to judge its severity, and to better manage patients.

Cookies are used on this website

Use of cookies
Confirm your account with Radiometer

Please enter a valid email

CONTINUE
By submitting your e-mail you agree to the data policy notice
Radiometer is using Microsoft Azure Active Directory to authenticate customer access. If you are already registered you will be taken to Microsoft AD to sign in using your Microsoft AD credentials.
You are already registered
Radiometer is using Microsoft Azure AD to authenticate customer access. If you are already registered you will be taken to AZURE to sign in using your AZURE credentials.
Thank you

We will be sending an e-mail invitation to you shortly to sign in using Microsoft Azure AD.

Radiometer is using Microsoft Azure AD to authenticate customer access.
Sorry

It seems that your e-mail is not registered with us

Radiometer is using Microsoft Azure AD to authenticate customer access. If your e-mail is not registered with us please click CONTINUE and we will guide you through the sign-in process.
We have previously sent an invitation by e-mail

Please click "Get started" in the e-mail to complete the registration process

Radiometer is using Microsoft Azure AD to authenticate customer access.
Sorry

We were not able to process your request due to a communication error

Sorry

It seems this account has not been given access to the portal

Radiometer is using Microsoft AZURE Active Directory to authenticate users

Radiometer uses Azure AD to provide our customers and partners secure access to documents, resources, and other services on our customer portal.

If your organization is already using Azure AD you can use the same credentials to access Radiometer's customer portal.

Key benefits

       
  • Allow the use of existing Active Directory credentials
  • Single-sign on experience
  • Use same credentials to access future services

Request access

You will receive an invitation to access our services via e-mail when your request has been approved.

When you accept the invitation, and your organization is already using AZURE AD, you can use the same credentials to access Radiometer's customer portal. Otherwise, an account will be created for you automatically.